返回
TYK Medicines, Inc（02410.HK）价格
02410.HK 股价走势图
TYK MEDICINES-B (02410.HK)
TYK Medicines, Inc
HK$12.8
1.58%
$0.2
休市： Feb 13, 16:00:00 HKT
关键数据
前收盘价
$12.67
开盘价
$12.6
当日区间
$12.58 - $12.88
52周范围
$12.1 - $46.1
交易量
1.1M
平均成交量
2.9M
每股收益（TTM）
-0.85
股息收益率
--
市值
$4.8B
什么是 TYK MEDICINES-B？
TYK Medicines, Inc. operates as a clinical-stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai and currently employs 163 full-time employees. The company went IPO on 2024-08-20. The firm is primarily focused on small molecule drug development, and its main products include TY-9591, TY-302 and TY-2136. TY-9591 is a third-generation EGFR-TKI with antitumor effects on EGFR mutations. TY-302 is a potent, selective oral CDK4/6 inhibitor developed for the treatment of advanced solid tumors, including breast cancer and prostate cancer. TY-2136b is an internally developed, oral ROS1/NTRK inhibitor for the treatment of solid tumors.